Supply of medicinal drug: meglumine sodium succinate (VZNLP)

This government procurement tender from Russia, sourced via gosplan_ru, concerns the supply of a specific pharmaceutical product: 'Meglumine Sodium Succinate' (меглюмина натрия сукцинат), designated as essential (ЖНВЛП - ZhN VLP, meaning 'Vital and Essential Drugs List'). This indicates a critical need for this medication by a healthcare institution, such as a hospital, clinic, or pharmacy. The tender will specify the required dosage form (e.g., solution for injection), packaging size, total quantity, and quality standards (e.g., pharmacopoeia compliance). Suppliers must be licensed pharmaceutical distributors or manufacturers. Key requirements include providing proof of product registration in Russia, valid manufacturing licenses, and adherence to Good Distribution Practices (GDP) and Good Manufacturing Practices (GMP). The tender evaluation will prioritize product quality, safety, confirmed availability, reliable supply chain management, and competitive pricing. The urgency and essential nature of this drug mean that delivery timelines and supply continuity will be critical factors. This procurement ensures access to a vital medication for patient treatment.